Multilocus sequence typing of Bordetella pertussis based on surface protein genes

被引:111
作者
van Loo, IHM
Heuvelman, KJ
King, AJ
Mooi, FR
机构
[1] Natl Inst Publ Hlth & Environm, Lab Infect Dis Res, NL-3720 BA Bilthoven, Netherlands
[2] Univ Utrecht, Med Ctr, Eijkman Winkler Inst Med Microbiol, Utrecht, Netherlands
关键词
D O I
10.1128/JCM.40.6.1994-2001.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Despite more than 50 years of vaccination, Bordetella pertussis has remained endemic in The Netherlands, causing epidemic outbreaks every 3 to 5 years. Strain variation may play a role in the persistence of B. pertussis and was studied by sequencing 15 genes coding for surface proteins, including genes for all five components of acellular pertussis vaccines: pertussis toxin (Ptx), pertactin (Pro), filamentous hemagglutinin, and fimbriae (Fim2 and Fim3). A low level of allelic variation was observed, confirming a recent evolutionary origin of B. pertussis. In modern isolates, polymorphism was observed only in prn, ptxS1, ptxS3, and tcfA. Polymorphism in ptxS1, ptxS3, and tcfA was used to categorize isolates in multilocus sequence types (MLSTs). Analysis of Dutch isolates from 1949 to 1999 revealed five MLSTs, which showed a highly dynamic temporal behavior. We observed significant changes in the MLSTs after the introduction of pertussis vaccination in The Netherlands. Epidemic years were found to be associated with the expansion of MLST-4 or MLST-5. MLST-5 showed a remarkable expansion from 10% in 1997 to 80% in 1999. The MLST analysis was extended to a number of widely separated geographic regions: Finland, Italy, Japan, and the United States. MLST-4 and MLST-5 were found to dominate in Italy and the United States. In Finland and Japan, MLST-3 and MLST-2, respectively, were predominant. Thus, although each region showed distinctive MLST frequencies, in three of the five regions MLST-4 and MLST-5 were predominant. These types may represent newly emerged, successful clones. The identification of highly successful clones may shed light on the question of how B. pertussis is able to maintain itself in vaccinated populations.
引用
收藏
页码:1994 / 2001
页数:8
相关论文
共 38 条
[1]  
Andrews R, 1997, Commun Dis Intell, V21, P145
[2]   BORDETELLA-PERTUSSIS MAJOR OUTER-MEMBRANE PORIN PROTEIN FORMS SMALL, ANION-SELECTIVE CHANNELS IN LIPID BILAYER-MEMBRANES [J].
ARMSTRONG, SK ;
PARR, TR ;
PARKER, CD ;
HANCOCK, REW .
JOURNAL OF BACTERIOLOGY, 1986, 166 (01) :212-216
[3]   RETURN OF EPIDEMIC PERTUSSIS IN THE UNITED-STATES [J].
BASS, JW ;
WITTLER, RR .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (05) :343-345
[4]   Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999 [J].
Cassiday, P ;
Sanden, G ;
Heuvelman, K ;
Mooi, F ;
Bisgard, KM ;
Popovic, T .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1402-1408
[5]   IDENTIFICATION AND CHARACTERIZATION OF A PROTECTIVE IMMUNODOMINANT B-CELL EPITOPE OF PERTACTIN (P.69) FROM BORDETELLA-PERTUSSIS [J].
CHARLES, IG ;
LI, JL ;
ROBERTS, M ;
BEESLEY, K ;
ROMANOS, M ;
PICKARD, DJ ;
FRANCIS, M ;
CAMPBELL, D ;
DOUGAN, G ;
BRENNAN, MJ ;
MANCLARK, CR ;
JENSEN, MA ;
HERON, I ;
CHUBB, A ;
NOVOTNY, P ;
FAIRWEATHER, NF .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (05) :1147-1153
[6]  
CHERRY JD, 1998, VACCINE, V16, P2039
[7]   Reemergence of pertussis in the highly vaccinated population of the Netherlands:: Observations on surveillance data [J].
de Melker, HE ;
Schellekens, JFP ;
Neppelenbroek, SE ;
Mooi, FR ;
Rümke, HC ;
Conyn-van Spaendonck, MAE .
EMERGING INFECTIOUS DISEASES, 2000, 6 (04) :348-357
[8]  
De Serres G, 1995, Can Commun Dis Rep, V21, P45
[9]   Pertussis in the Netherlands: An outbreak despite high levels of immunization with whole-cell vaccine [J].
deMelker, HE ;
ConynvanSpaendonck, MAE ;
Rumke, H ;
vanWijngaarden, JK ;
Mooi, FR ;
Schellekens, JFP .
EMERGING INFECTIOUS DISEASES, 1997, 3 (02) :175-178
[10]   Multilocus sequence typing system for Campylobacter jejuni [J].
Dingle, KE ;
Colles, FM ;
Wareing, DRA ;
Ure, R ;
Fox, AJ ;
Bolton, FE ;
Bootsma, HJ ;
Willems, RJL ;
Urwin, R ;
Maiden, MCJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) :14-23